Trial Profile
Phase II study evaluating non-pegylated liposomal doxorubicin and dexamethasone in immunocompetent patients with refractory or relapsed brain lymphoma in first-line chemotherapy with high-dose methotrexate (MTXHD) and / or high-dose cytarabine.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2013
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Dexamethasone
- Indications B-cell lymphoma
- Focus Therapeutic Use
- Acronyms MYLY
- 11 Jun 2013 New trial record